obesity, research, health, graduate, phd he future is very promising for the scientists the Merck FrosstÕs Centre for therapeutic research. Thanks to our work on asthma and arthritis shown by our discovery of SINGULAR¨ (montelukast sodium) and of VIOXX¨ (rofecoxib), we have become the world leaders in the understanding of the inflammatory process, and especially in the chemistry and biology of leukotriene and prostaglandins.
|
